A study of pharmacokinetic analysis of capecitabine and cytidine deaminase activity
Not Applicable
- Conditions
- Breast and colorectal cancer
- Registration Number
- JPRN-UMIN000019244
- Lead Sponsor
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients that administration of capacitabine is contraindicated 2)Patients with administration of warfarin 3)Patients with active infections 4)Patients who judged by investigator to be inappropriate for study participation for serious psychiatric condition 5)Patients who judged by investigator to be inappropriate for study participation for any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the correlation AUC of 5-DFUR/AUC of 5-DFCR ratio and cytidine deaminase activity.
- Secondary Outcome Measures
Name Time Method